Patent
Proton therapy tuning apparatus and method of use thereof
| العنوان: | Proton therapy tuning apparatus and method of use thereof |
|---|---|
| Patent Number: | 11918,830 |
| تاريخ النشر: | March 05, 2024 |
| Appl. No: | 17/382044 |
| Application Filed: | July 21, 2021 |
| مستخلص: | The invention comprises a method and apparatus for tuning a charged particle beam path of a charged particle beam system used to treat a tumor of a patient, comprising the steps of: positioning a two-dimensional charged particle detector in a beam line downstream from a magnet pair; operating windings of the magnet pair at a first power level to generate a first magnetic field; measuring a beam position with the first two-dimensional charged particle detector; adjusting a correction magnetic field by driving voltage of a correction coil at a second power level, the second power level less than five percent of the first power level, where the first magnetic field and the correction magnetic field combine to yield an operational magnetic field; and the steps of measuring and adjusting the correction magnetic field changing the operational magnetic field to adjust a measured beam position toward a target beam position. |
| Inventors: | Michaud, Susan L. (Brewster, MA, US); Raymond, Daniel J. (Windham, NH, US); Teymurazyan, Artur (Shrewsbury, MA, US); Tu, Ran (Malden, MA, US) |
| Claim: | 1. A method for tuning a positively charged particle beam path in a gap of a charged particle beam system used to treat a tumor of a patient with positively charged particles, comprising the steps of: positioning a first two-dimensional charged particle detector in a beam line downstream from a first upstream magnet pair of a cancer therapy system, said beam line running at least from an injector, through a synchrotron, and along a beam transport line to a patient position; operating windings of said first upstream magnet pair at a first power level to generate a first magnetic field across the gap; measuring a beam position with said first two-dimensional charged particle detector; adjusting a correction magnetic field by driving voltage of a correction coil at a second power level, said second power level less than five percent of said first power level, wherein the first magnetic field and the correction magnetic field combine to yield an operational magnetic field during use; and said steps of measuring and adjusting the correction magnetic field changing the operational magnetic field to adjust a measured beam position toward a target beam position. |
| Claim: | 2. The method of claim 1 , further comprising the steps of: altering a voltage of a second upstream magnet pair to yield an altered magnetic field about the positively charged particle beam path; and said steps of measuring, adjusting, and altering moving the positively charged particle beam path toward a target beam position. |
| Claim: | 3. The method of claim 1 , further comprising the steps of: passing a current through an organic semi-conducting film of said first two-dimensional charged particle detector. |
| Claim: | 4. The method of claim 1 , further comprising the step of: said step of positioning, placing at least a mounting element of said first two-dimensional charged particle detector between a flattened coil end of said first upstream magnet pair and a downstream magnet pair, said first upstream magnet pair comprising a core and a first winding, said first winding comprising a first width and a first thickness along a path parallel to the gap and a second width and a second thickness in a space between said first upstream magnet pair and said downstream magnet pair, said first width greater than 1.5 times said second width and said second thickness greater than 1.5 times said first thickness. |
| Claim: | 5. The method of claim 1 , further comprising the steps of: placing a set of two-dimensional charged particle detectors, comprising said first two-dimensional charged particle detector, in said beam line; tuning said beam line of said cancer therapy system with said set of two-dimensional charged particle detectors; and without removing said set of two-dimensional charged particle detectors from said beam line, dynamically tuning said beam line during a treatment session of the patient. |
| Claim: | 6. The method of claim 1 , further comprising the step of: auto-tuning the positively charged particle beam path, said step of auto-tuning comprising the steps of: measuring an incorrect beam shape of the charged particle beam path with said first two-dimensional charged particle detector; selecting a condition-action rule, based upon a classification of said incorrect beam shape; and applying a first altered voltage, according to the selected condition-action rule, to said first upstream magnet pair to adjust the operational magnetic field to yield an at least partially corrected beam shape of the charged particle beam path. |
| Claim: | 7. The method of claim 6 , further comprising the step of: altering a supplied voltage, according to the selected condition-action rule, to a first downstream magnet pair to further adjust the operational magnetic field to further correct the charged particle beam path. |
| Claim: | 8. The method of claim 5 , comprising the step of: determining an altered beam alignment from a planned beam alignment during a treatment session of the tumor of the patient; recording at least one missed tumor voxel, resultant from the determined altered beam alignment, during the treatment session; and dynamically altering magnet fields of the cancer therapy system to treat said missed tumor voxel. |
| Claim: | 9. The method of claim 1 , further comprising the step of: treating the tumor with the positively charged particles, where greater than ninety-percent of the positively charged particles in the treatment pass entirely through the patient. |
| Patent References Cited: | 7378672 May 2008 Harada 20030183779 October 2003 Norimine 20080006776 January 2008 Furukawa 20090114852 May 2009 Saito 20090283702 November 2009 Umezawa 20090296885 December 2009 Boeh 20090309046 December 2009 Balakin 20100207552 August 2010 Balakin 20210353966 November 2021 Michaud 20210387022 December 2021 Raymond |
| Primary Examiner: | Vanore, David A |
| Attorney, Agent or Firm: | Hazen, Kevin H. Hazen Patent Group, LLC |
| رقم الانضمام: | edspgr.11918830 |
| قاعدة البيانات: | USPTO Patent Grants |
| الوصف غير متاح. |